Early data from Moderna COVID-19 vaccine show it produced antibodies. The study showed the vaccine was safe and all study participants produced antibodies against COVID-19. The vaccine was tested in a small trial of 45 healthy people. (Reuters)
The Centers for Disease Control and Prevention has warned of measles outbreaks due to the fall in routine doctor visits and vaccinations during the pandemic. The CDC said “concerted efforts” are needed to ensure children are caught up on their vaccines. (CNBC)
New York City may begin reopening in the first half of June, city officials said. The first phase of reopening allows construction to resume and retailers to open with some limitations. The city is meeting three of the New York state’s reopening guidelines, including a decline in hospitalizations, deaths and increased testing. (CNBC)
The World Health Organization leaders have agreed to a review of its coronavirus response. More than 100 countries called for the independent review. The review will look at lessons learned from the response and make recommendations for future preparedness. (U.S. News & World Report)
Bristol Myers Squibb has won approval for Opdivo and Yervoy in some patients with non-small cell lung cancer from the Food and Drug Administration. The approval gives BMS entry into the lung cancer market, Merck and Roche already have approved immunotherapies in this disease area. (BioPharma Dive)
